• Avidity Biosciences Appoints Michael MacLean as Chief Financial Officer

    6 days ago - By San Diego Biotechnology

    SAN DIEGO, May 19, 2020 /PRNewswire/ - Avidity Biosciences , a privately-held biopharmaceutical company pioneering Antibody Oligonucleotide Conjugates , announced today the appointment of Michael MacLean as Chief Financial Officer.......
    Read more ...

     

  • Amplyx Pharmaceuticals Advances Development of Novel Antifungal, Fosmanogepix

    6 days ago - By San Diego Biotechnology

    Completes Enrollment of Phase 2 Candida TrialTreats First Patients in Phase 2 Trials in Aspergillus and Candida auris Infections
    SAN DIEGO, May 19, 2020 /PRNewswire/ - Amplyx Pharmaceuticals, a biotech company developing innovative therapies for deb......
    Read more ...

     

  • Cardiff Oncology Announces Private Placement Investment by Board of Directors and Chief Executive Officer

    6 days ago - By San Diego Biotechnology

    SAN DIEGO, May 19, 2020 /PRNewswire/ - Cardiff Oncology, Inc. , a clinical-stage oncology therapeutics company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorect......
    Read more ...

     

  • Oncternal Therapeutics Announces Presentation of Update on Phase 1/2 Clinical Trial of Cirmtuzumab in Combination with Ibrutinib at 2020 ASCO Annual Meeting

    6 days ago - By San Diego Biotechnology

    SAN DIEGO--Oncternal Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced updated interim clinical data from the ongoing Phase 1/2 CIRLL (......
    Read more ...